Delivery Order SPE2DB22D9304-SPE2DB24FSSJ6

Award Date 11/15/23
Potential Completion Date 12/7/23
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency to provide Xolair 150 mg/1.2 ml powder vials. The delivery order was issued on December 5, 2023 against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-eight thousand six hundred eighty-five dollars ($38,685) by the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars ($5,000,000) through December...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at ten thousand eight hundred thirty-one dollars and eighty cents ($10,831.80) by the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. No...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand six hundred forty-two dollars and twenty cents ($4,642.20) by the Defense Logistics Agency. The delivery order is issued against an indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to the Defense Logistics Agency through December 2025, with a potential value of up to five million dollars. Under this delivery order, DMS...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand five hundred forty-seven dollars and forty cents ($1,547.40) by the Defense Logistics Agency Troop Support Medical. The delivery order is for the supply of Xolair 75 MG/0.5 ML syringes to fulfill requirements at Park Ridge, Illinois. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, with a...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $23,984.70 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150MG/ML SYR 1S. The delivery order has a completion date of December 12, 2023 and was awarded on the same date by the Defense Logistics Agency Troop Support Medical. DMS Pharmaceutical Group Inc. will fulfill the delivery order from its location in Park Ridge, Illinois. As a woman-owned small business and...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand ninety-four dollars and eighty cents ($3,094.80) by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025. No...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,547.40 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. The delivery order was awarded on December 6, 2023 and has a completion date of December 28, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the delivery order as the prime contractor, supplying the pharmaceutical item to Defense Logistics Agency...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand five hundred forty-seven dollars and forty cents ($1,547.40) by the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars ($5,000,000) through December 2025....
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency to provide 4562922799 units of XOLAIR 150 MG/1.2 ML POWDER VLS. The place of performance is Park Ridge, Illinois and the completion date is December 15, 2023. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB24FSSJ6
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand one hundred thirty-seven dollars and sixty cents ($37,137.60) by the Defense Logistics Agency to supply XOLAIR 150 MG/1.2 ML POWDER VLS. The place of performance is Park Ridge, Illinois and the completion date is December 7, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, with a potential value of up to five million dollars ($5,000,000), to provide pharmaceuticals and medical supplies through December 2025. This delivery order is issued against that contract vehicle to fulfill requirements for the specified product at military treatment facilities supported by the Defense Logistics Agency.

Generated 2/14/24, 9:07 AM